BioWorld-International-2002-07-10

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

DUBLIN, Ireland - The top slot at ailing Irish biopharmaceutical firm Elan Corp. plc became available Tuesday as Chairman and CEO Donal Geaney vacated both roles, following a share price meltdown last Thursday, when Standard & Poor's reduced the company's debt rating to junk bond status. (BioWorld International)

No Abstract

No Abstract

No Abstract